Detalhe da pesquisa
1.
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Ann Oncol
; 34(4): 397-409, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709040
2.
Lasofoxifene versus fulvestrant for ER+/HER2- metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial.
Ann Oncol
; 34(12): 1141-1151, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072514
3.
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.
Ann Oncol
; 30(4): 551-557, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30753272
4.
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.
Ann Oncol
; 33(6): 658, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301096
5.
Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.
Ann Oncol
; 28(9): 2225-2232, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28911092
6.
A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II Consortia.
Gynecol Oncol
; 138(1): 55-61, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25895616
7.
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia.
Gynecol Oncol
; 125(1): 136-40, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22138373
8.
The impact of sharing results of a randomized breast cancer clinical trial with study participants.
Breast Cancer Res Treat
; 115(1): 123-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18543100
9.
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Ann Oncol
; 19(7): 1231-1241, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18325918
10.
An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 108(1): 3-9, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17945336
11.
Phase I study of adozelesin administered by 24-hour continuous intravenous infusion.
J Natl Cancer Inst
; 86(5): 368-72, 1994 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-8308929
12.
Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer.
J Clin Oncol
; 16(6): 2032-7, 1998 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-9626200
13.
Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.
J Clin Oncol
; 19(4): 1021-9, 2001 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11181665
14.
Phase II evaluation of thalidomide in patients with metastatic breast cancer.
J Clin Oncol
; 18(14): 2710-7, 2000 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10894870
15.
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study.
J Clin Oncol
; 15(1): 177-86, 1997 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-8996140
16.
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.
J Clin Oncol
; 19(5): 1539-69, 2001 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11230499
17.
Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.
Clin Cancer Res
; 6(10): 4043-8, 2000 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-11051254
18.
Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer.
Clin Cancer Res
; 7(5): 1214-20, 2001 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11350886
19.
Etoposide combined with interferon alfa-2b: novel exploitation of established etoposide pharmacokinetics and pharmacodynamics.
Clin Pharmacol Ther
; 59(3): 349-59, 1996 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-8653998
20.
Invariant p53 immunostaining in primary and recurrent breast cancer.
Eur J Cancer
; 40(1): 28-32, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14687786